The Effects of Inhaled Nitric Oxide After Fontan Operation
NCT00945529 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 21
Last updated 2023-05-19
Summary
Pleural effusions continue to be a post-operative complication seen after Fontan operation. This study will examine the use inhaled nitric oxide (iNO) given for 54 hours after Fontan operation to improve fluid balance. The study hypothesis is that inhaled nitric oxide after Fontan operation will improve fluid balance, thus decreasing the incidence of pleural effusions and shortening hospital stay.
Conditions
- Congenital Heart Defect
Interventions
- DRUG
-
inhaled nitric oxide (iNO)
Inhaled nitric oxide 40ppm for 48 hours followed by a 6-hour wean.
Sponsors & Collaborators
-
Mallinckrodt
collaborator INDUSTRY -
Ellen Spurrier
lead OTHER
Principal Investigators
-
Ellen Spurrier, MD · Nemours Children's Clinic - A. I. duPont Hospital for Children
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 1 Year
- Max Age
- 5 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-02-29
- Primary Completion
- 2011-12-31
- Completion
- 2011-12-31
Countries
- United States
Study Locations
More Related Trials
-
Study of Inhaled Nitric Oxide (iNO) and Respiratory Outcomes in Late Preterm Infants
NCT01748045 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
NO Need to Ventilate: A Trial of Non-invasive Inhaled Nitric Oxide in Persistent Pulmonary Hypertension of the Newborn
NCT00139217 ·Status: COMPLETED ·Phase: NA
-
Inhaled Nitric Oxide in Neonates With Elevated A-a DO2 Gradients Not Requiring Mechanical Ventilation
NCT00041548 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Follow-up at School-age of Children Who Participated in the Efficacy Study of Nitric Oxide for Premature Infants
NCT00152542 ·Status: COMPLETED ·Phase: PHASE3
-
Nitric Oxide Administration for Acute Respiratory Distress Syndrome
NCT00240487 ·Status: COMPLETED ·Phase: PHASE3
-
Inhaled Nitric Oxide for ARDS-related Pulmonary Hypertension
NCT06249633 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Inhaled NO in Prevention of Chronic Lung Disease
NCT00000548 ·Status: COMPLETED ·Phase: PHASE3
-
Dead Space and Inhaled Nitric Oxide in Pediatric Acute Respiratory Distress Syndrome
NCT06690801 ·Status: RECRUITING
-
Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure
NCT00016523 ·Status: TERMINATED ·Phase: PHASE3
-
Trial of Late Surfactant for Prevention of Bronchopulmonary Dysplasia
NCT01022580 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Nitric Oxide for Inhalation on Chronic Lung Disease in Premature Babies
NCT00551642 ·Status: COMPLETED ·Phase: PHASE3
-
Inhaled Nitric Oxide for Pulmonary Hypertension and Bronchopulmonary Dysplasia
NCT03576885 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Pilot Trial of Surfactant Booster Prophylaxis For Ventilated Preterm Neonates
NCT00208039 ·Status: COMPLETED ·Phase: NA
-
Trial of Late Surfactant to Prevent BPD: A Pilot Study in Ventilated Preterm Neonates Receiving Inhaled Nitric Oxide
NCT00569530 ·Status: COMPLETED ·Phase: PHASE3
-
Inhaled Nitric Oxide for the Treatment of Neonatal Hypoxic Respiratory Failure With Pulmonary Hypertension
NCT07099144 ·Status: RECRUITING
-
Inhaled Nitric Oxide for Cardiac Arrest in Pediatrics and Adults (iNOCAPA)
NCT05868109 ·Status: RECRUITING ·Phase: PHASE2
-
Premedication for Non-Emergency Endotracheal Intubation In the NICU
NCT01749501 ·Status: COMPLETED ·Phase: PHASE4
-
Inhaled Nitric Oxide Study for Respiratory Failure in Newborns
NCT00005776 ·Status: TERMINATED ·Phase: PHASE3
-
Pilot Trial of Surfactant Therapy For Preterm Neonates 5-21 Days Old With Respiratory Decompensation
NCT00165074 ·Status: COMPLETED ·Phase: NA
-
Acute Effects of Inhaled Treprostinil in Fontan Patients
NCT02769624 ·Status: TERMINATED ·Phase: PHASE2
-
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
NCT00006401 ·Status: COMPLETED ·Phase: PHASE3
-
Prolonged Outcomes After Nitric Oxide (PrONOx)
NCT00234247 ·Status: COMPLETED
-
Inhaled Nitric Oxide to Prevent and Treat Bronchopulmonary Dysplasia
NCT01503801 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Role of Salbutamol and Furosemide in TTN
NCT03208894 ·Status: COMPLETED ·Phase: PHASE3
-
A Pharmacokinetic Study of Dexmedetomine in Infants
NCT00459082 ·Status: COMPLETED ·Phase: PHASE1